- Description
- Additional
Description
Details
Description:Mouse monoclonal antibody to human Monocyte Chemotactic Protein-1 (MCP-1)/ Monocyte Chemotactic and Activating Factor (MCAF)
Purification: Protein G affinity purified
Product Type:Detection antibody in matched antibody pair
Target Protein:Human MCP-1
Immunogen:Purified recombinant human MCP-1
Fusion Myeloma:Sp2/0-Ag14
Specificity:This antibody reacts with natural and recombinant human MCP-1.
Species Reactivity: Human, others not tested.
Cross-reactivity:This antibody does not react with human interleukin-8 (IL-8) and other human cytokines tested such as interleukin-1β (IL-1β), serum amyloid A (SAA) and epidermal growth factor (EGF).
Host / Isotype: Mouse, IgG1 Kappa
Formulation:Lyophilized from a solution in 0.01M PBS, pH 7.2
Reconstitution:Double distilled water is recommended to adjust the final concentration to 1.00 mg/mL.
Storage: Store at -20oC
Research Area:Cytokine, chemotaxis, inflammation
Background:
Monocyte chemotactic and activating factor (MCAF) is also called monocyte chemotactic protein-1 (MCP-1) and chemokine (C-C motif) ligand 2 (CCL2). It is primarily secreted by monocytes, macrophages and dendritic cells. This cytokine displayed chemotactic activity for monocytes, T-cells, and basophils, but not for neutrophils or eosinophils. MCAF causes the degranulation of basophils and mast cells, and augments the activity of monocyte and macrophage. MCAF plays an important role in inflammation, angiogenesis, auto-immune diseases, renal diseases, chronic infection and granuloma formation.
Applications:
ELISA:The antibody can be used for quantitative detection of human MCP-1 in sandwich ELISA in combination with capture antibody S14 (MO-C40021B).
Western Blot:0.1μg/lane of recombinant human MCP-1 can be detected when antibody is used at 0.1-1μg/mL.
Neutralizing:The antibody at a concentration of 0.5μg/mL, neutralized 1nM recombinant human MCP-1 induced monocyte chemotaxis in blind well chemotaxis chambers.
References:
1. Randolph, G. J. and Furie, M. B. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J. Immunol. 1995 155:3610-3618.
2. Gwendalyn J. Randolph and Martha B. Furie. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J Exp Med. Feb 1, 1996; 183(2): 451–462.
3. Mehrdad Baghestanian et al. The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells. Blood. December 1, 1997 vol. 90 no. 11 4438-4449.
If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.
Additional
Additional Information
| Product Specificity | mAb anti-Human MCP-1, S101, Detector |
|---|---|
| Application | ELISA, NT, WB |
| Size | 0.1 mg |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
本研究从新合成的十种核苷类似物中筛选具有抗肿瘤活性的化合物, 观察其抑制肿瘤细胞增殖、诱导细胞凋亡的作用,并探讨可能的作用机制。
郎格罕斯细胞组织细胞增生症(Langerhanscellhistiocytosis)或郎格罕斯细胞病(Langerhans#39;celldisease)又称组织细胞增生症X(HistiocytosisX),为一组少见的,以郎格罕斯细胞增生为主的疾病.本病的病因和发病机制尚不清楚,有人认为是反应性疾病,而非真性肿瘤.也有人认为本病是免疫系统异常所致,但通过PCNA免疫组化可见较多的阳性细胞,且病变中常见核分裂象故认为是增生性疾病,可能为肿瘤性增生。这种病要看医生。
细胞增殖是生物体生长、发育、繁殖和遗传的基础。
解析：细胞增殖是重要的细胞生命特征。
自噬是一个吞噬自身细胞质蛋白或细胞器并使其包被进入囊泡，并与溶酶体融合形成自噬溶酶体，降解其所包裹的内容物的过程，藉此实现细胞本身的代谢需要和某些细胞器的更新。
原核生物比如大肠杆菌促进增殖药物还不如提供更好的营养条件、足够的环境；抑制类药物如上。
根据细胞种类不同，可能需要不同成分的培养液，来达到促进/抑制的作用
做一个药物对细胞增殖和迁移的抑制的研究，已知药物对细胞增殖有影响，想要继续做迁移实验，怎么排除药物对细胞的抑制作用对细胞迁移产生的影响？谢谢大家！
方式：真核生物的分裂依据过程不同有三种方式，有有丝分裂，无丝分裂，减数分裂。其中有丝分裂是人、动物、植物、真菌等一切真核生物中的一种最为普遍的分裂方式，是真核细胞增殖的主要方式。减数分裂是生殖细胞形成时的一种特殊的有丝分裂。向左转|向右转
